AU454533B2 - Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof - Google Patents

Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof

Info

Publication number
AU454533B2
AU454533B2 AU33849/71A AU3384971A AU454533B2 AU 454533 B2 AU454533 B2 AU 454533B2 AU 33849/71 A AU33849/71 A AU 33849/71A AU 3384971 A AU3384971 A AU 3384971A AU 454533 B2 AU454533 B2 AU 454533B2
Authority
AU
Australia
Prior art keywords
spirox
animals
ones
derivatives
growth promotion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU33849/71A
Other languages
English (en)
Other versions
AU3384971A (en
Inventor
JEAN PATANELLI and GLEN EDWARD AETH DOLORES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU3384971A publication Critical patent/AU3384971A/en
Application granted granted Critical
Publication of AU454533B2 publication Critical patent/AU454533B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU33849/71A 1970-10-06 1971-09-23 Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof Expired AU454533B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7863670A 1970-10-06 1970-10-06
USUS78636 1970-10-06

Publications (2)

Publication Number Publication Date
AU3384971A AU3384971A (en) 1973-03-29
AU454533B2 true AU454533B2 (en) 1974-10-31

Family

ID=22145320

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33849/71A Expired AU454533B2 (en) 1970-10-06 1971-09-23 Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof

Country Status (6)

Country Link
US (1) US3670079A (enExample)
AU (1) AU454533B2 (enExample)
CA (1) CA968710A (enExample)
DE (1) DE2149744A1 (enExample)
FR (1) FR2110251B1 (enExample)
GB (1) GB1350114A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013762A (en) * 1976-05-10 1977-03-22 Richardson-Merrell Inc. Growth promotion
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CZ20023993A3 (cs) * 2000-06-26 2004-02-18 Pfizer Products Inc. Pyrolo [2,3-d]pyrimidinové sloučeniny jako imunosupresivní činidla
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2006239221C1 (en) 2005-04-28 2012-08-16 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
PL2384326T3 (pl) 2008-08-20 2014-09-30 Zoetis Services Llc Związki pirolo[2,3-d]pirymidyonowe
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones

Also Published As

Publication number Publication date
GB1350114A (en) 1974-04-18
AU3384971A (en) 1973-03-29
CA968710A (en) 1975-06-03
FR2110251B1 (enExample) 1975-06-06
DE2149744A1 (de) 1972-04-13
US3670079A (en) 1972-06-13
FR2110251A1 (enExample) 1972-06-02

Similar Documents

Publication Publication Date Title
AU454533B2 (en) Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof
AU465751B2 (en) Interferon induction in animals by amines
CA927860A (en) Toy animal
AU465597B2 (en) Azetidinane derivatives and their preparation
CA919592A (en) Methods and preparations for obtaining diureses in animals including man
CA927661A (en) Guanidines employed in animal husbandry
AU1731270A (en) Improvements in or relating to animal traps
AU431569B2 (en) Improvements in and relating to animal milkin apparatus
CA842841A (en) 6-diloweralkylamino-fluoran derivatives and their preparation and use
CA847314A (en) Methods and compositions for use in animal husbandry
AU458339B2 (en) Methods and preparations for obtaining diuresis in animals, including man
AU2808671A (en) Improvements in and relating to animal milkin apparatus
AU466898B1 (en) Improvement in ground augers
AU453864B2 (en) Improvements in and relating to conveyors
CA867336A (en) Methods and compositions in animal husbandry
CA838660A (en) Animal repellent composition and methods
AU440491B2 (en) Improvements in and relating to the branding of animals
AU470138B2 (en) Improvements in and relating to benzenesulphonylurea derivatives
AU2704471A (en) Methods and preparations for obtaining diuresis in animals, including man
AU455055B2 (en) Improvements in transistorized amplifiers
CA950286A (en) Apparatus for raising and harvesting fish
AU3732771A (en) Improvements in and relating to conveyors
CA856818A (en) 4-phenyl-8-amino-isoquinoline and derivatives thereof
CA852411A (en) Crop stores and silos
AU455287B2 (en) Indolazonine and indolazecine derivatives